Akums Drugs and Pharmaceuticals Limited IPO (Akums Drugs and Pharmaceuticals IPO)

Akums Drugs and Pharmaceuticals Limited IPO
Upcoming Akums Drugs and Pharmaceuticals IPO | New Akums Drugs and Pharmaceuticals IPO

Akums Drugs and Pharmaceuticals Limited is a pharmaceutical contract development and manufacturing organization (CDMO) offering a comprehensive range of pharmaceutical products and services in India and overseas.

The company primarily provides end-to-end solutions for product development and manufacturing as well as research and development (R&D) of formulations, preparation and submission of regulatory dossiers in the Indian and global markets and other testing services. The company is also engaged in the manufacture and sale of branded drugs and active pharmaceutical ingredients (APIs).

As a CDMO, the company manufactures a wide range of dosage forms including tablets, capsules, liquid medicines, vials, ampoules, blow-filled closures, topical preparations, eye drops, dry powder injections and gummy bears, to name a few.

The company has produced a total of 4,025 commercialized formulations in over 60 dosage forms. In the financial year 2023, the company manufactured formulations for 26 of the top 30 pharmaceutical companies in India in terms of revenue. For its CDMO business, the company operates 10 manufacturing units with a cumulative production capacity of 49.21 billion units annually (as of September 30, 2023).

The company plans to expand its production capacity with two additional production units for its CDMO business to be commissioned in FY 2025. Some of its production facilities have been accredited by various global regulatory bodies such as the European Good Manufacturing Practice (EU-GMP), the World Health Organization Good Manufacturing Practice (WHO-GMP) and the United States National Sanitation Foundation (US NSF).

As of September 30, 2023, Akums Drugs and Pharmaceuticals had a total of 16,463 employees, including 7,211 full-time employees and 9,252 contract employees.

Akums Drugs and Pharmaceuticals IPO

Akums Drugs and Pharmaceuticals IPO – Details

IPO Opening Date30 July 2024
IPO Closing Date01 August 2024
Issue TypeBook Built Issue IPO
Issue SizeTotal Issue Size: 2,73,45,162 Shares Worth ₹1,856.74 Crore
Fresh Issue: 1,00,14,727 Shares Worth ₹680.00 Crore
Offer For Sale: 1,73,30,435 Shares Worth ₹1,176.74 Crore
Face Value₹2 per equity share
IPO Price₹646 – ₹679 per share
Market Lot22 Shares
Min Order22 Shares ( 1 Lot )
Employee DiscountRs 64
Listing AtBSE, NSE
RegisterLink Intime India Private Ltd
QIB Shares Offered75%
NII (HNI) Shares Offered15%
Retail Shares Offered10%

Akums Drugs and Pharmaceuticals IPO – Date Schedule

IPO Open Date30 July 2024
IPO Close Date01 August 2024
Basis of Allotment02 August 2024
Initiation of Refund05 August 2024
Credit of Shares to Demat Account05 August 2024
IPO Listing Date06 August 2024
Cut-off time for UPI mandate confirmation5 PM on August 01, 2024

Akums Drugs and Pharmaceuticals IPO – Lots Size & Price

ApplicationLotsSharesAmount
Retail (Min)122₹14,938
Retail (Max)13286₹1,94,194
S-HNI (Min)14308₹2,09,132
S-HNI (Max)661452₹9,85,908
B-HNI (Min)671474₹10,00,846

Competitive Strengths

  • Largest India-focused CDMO serving the Indian domestic pharmaceutical industry (Source: F&S Report);
  • Diverse client base with longstanding CDMO relationships;
  • Large and rapidly growing R&D capabilities across its product portfolio;
  • Strategic presence across the pharmaceutical value chain; and
  • Experienced and entrepreneurial management team with a proven track record and marquee healthcare focused PE investor.

Company Promoters

  • Sanjeev Jain
  • Sandeep Jain
  • Akums Master Trust

Company Financials

ParticularsTotal RevenueTotal ExpenseProfit After TaxTotal Borrowing
31 March 20223694.523874.94-250.87357.95
31 March 20233700.923475.9297.81536.97
31 March 20244212.204231.450.79491.56
Amount in ₹ Crore

Key Performance Indicator

KPIValues
ROE0.11%
ROCE3.37%
Debt/Equity0.69
RoNW-0.57
P/BV13.69
PAT Margin (%)0.02

Object Of The Issue

  • Repayment/ prepayment of indebtedness of the company and its Subsidiaries;
  • Funding incremental working capital requirements of the company;
  • Pursuing inorganic growth initiatives through acquisitions; and
  • General corporate purposes.
Akums Drugs and Pharmaceuticals IPO
Object of the Issues

Akums Drugs and Pharmaceuticals IPO Peer Comparison

S. No.Face ValueCompany NamePE
12Divi’s Laboratories74.99
21Suven Pharma69.54
31Gland Pharma42.45
45Torrent Pharma60.20
52Alkem Laboratories34.18
61Eris Lifesciences34.95
71JB Chemicals51.38
81Mankind Pharma44.65
910Innova Captab29.91

Akums Drugs and Pharmaceuticals IPO Promoter Holding

Pre Issue Share Holding82.44%
Post Issue Share Holding66.18%

Akums Drugs and Pharmaceuticals IPO Prospectus

Company Contact Information

Akums Drugs and Pharmaceuticals Limited

304, Mohan Place,
LSC Saraswati Vihar,
Delhi – 110 034

Phone: +91 11 6904 1000
Email: cs@akums.net
Website: http://www.akums.in/

Akums Drugs and Pharmaceuticals IPO Registrar

Link Intime India Private Ltd

Phone: +91-22-4918 6270
Email: akumsdrugs.ipo@linkintime.co.in
Websitehttps://linkintime.co.in/initial_offer/public-issues.html

Akums Drugs and Pharmaceuticals IPO Lead Manager(s)

1. ICICI Securities Limited
2. Axis Capital Limited
3. Ambit Private Limited
4. Citigroup Global Markets India Private Limited

Akums Drugs and Pharmaceuticals IPO FAQs

Akums Drugs and Pharmaceuticals IPO FAQs
What is Akums Drugs and Pharmaceuticals IPO?

Akums Drugs and Pharmaceuticals IPO is a main-board IPO. The issue is priced at ₹646 to ₹679 per equity share. The IPO is to be listed on BSE & NSE.
When Akums Drugs and Pharmaceuticals IPO will open?

The IPO is to open on 30 July 2024 for QIB, NII, and Retail Investors.
What is Akums Drugs and Pharmaceuticals IPO Investors Portion?

The investors’ portion for QIB – 75%NII – 15%, and Retail – 10%.
How to Apply the Akums Drugs and Pharmaceuticals IPO?

You can apply Akums Drugs and Pharmaceuticals IPO via ASBA online via your bank account. You can also apply for ASBA online via UPI through your stock brokers. You can also apply via your stock brokers by filling up the offline form.
How to Apply the Akums Drugs and Pharmaceuticals IPO through Angle One?

Log in to Angle One Application with your credentials. Select the IPO. You will see the IPO Name “Akums Drugs and Pharmaceuticals IPO”. Click on Bid Button. Confirm your Application. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate. Open Demat Account with Angle One.
How to Apply the Akums Drugs and Pharmaceuticals IPO through 5 Paisa?

Log in to 5 Paisa Application with your credentials. Select the IPO. You will see the IPO Name “Akums Drugs and Pharmaceuticals IPO“. Click on Bid Button. Confirm your Application. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate. Open Demat Account with 5 Paisa.
How to Apply the Akums Drugs and Pharmaceuticals IPO through Upstox?

Log in to Upstox Application with your credentials. Select the IPO. You will see the IPO Name “Akums Drugs and Pharmaceuticals IPO”. Click on Bid Button. Confirm your Application. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate. Open Demat Account with Upstox.
How to Apply the Akums Drugs and Pharmaceuticals IPO through IIFL?

Log in to IIFL Application with your credentials. Select the IPO. You will see the IPO Name “Akums Drugs and Pharmaceuticals IPO”. Click on Bid Button. Confirm your Application. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate. Open Demat Account with IIFL.
What is Akums Drugs and Pharmaceuticals IPO Size?

Akums Drugs and Pharmaceuticals IPO size is ₹1,856.74 Crore.
What is Akums Drugs and Pharmaceuticals IPO Price Band?

Akums Drugs and Pharmaceuticals IPO Price Band is ₹646 to ₹679.
What is Akums Drugs and Pharmaceuticals IPO Minimum and Maximum Lot Size for retail?

The minimum bid is 22 Shares with ₹14,938 amount while the maximum bid is 286 Shares with ₹1,94,194.
What is the Akums Drugs and Pharmaceuticals IPO Allotment Date?

Akums Drugs and Pharmaceuticals IPO allotment date is 02 August 2024.
What is the Akums Drugs and Pharmaceuticals IPO Listing Date?

Akums Drugs and Pharmaceuticals IPO listing date is 06 August 2024. The IPO is to be listed on BSE and NSE.
Share Market IPO App
Previous articleRajputana Industries Limited IPO (Rajputana Industries IPO)
Next articleBulkcorp International Limited IPO (Bulkcorp International IPO)